Allison Humphries's Publications
About Allison Humphries's Publications
Senior Research Fellow, Respiratory Programme- Operations Lead, Academic Project Operations
-
Interdisciplinary lifestyle intervention: A pilot study of effects on weight loss
Journal of Nutrition & Intermediary Metabolism Date published: -
HIV Lipodystrophy in Participants Randomised to Lopinavir/Ritonavir (LPV/r) +2-3 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) or LPV/r + Raltegravir as Second-Line Antiretroviral Therapy
PLOS One Date published: -
Bone mineral density in HIV participants randomized to raltegravir and lopinavir/ritonavir compared with standard second line therapy
AIDS Date published: -
Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study
The Lancet Date published: -
Bone mineral density in HIV participants randomized to raltegravir plus lopinavir/ritonavir compared to standard second-line therapy.
AIDS Date published: -
Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard fi rst-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study.
Lancet Date published: -
The influence of HLA supertype on thymidine analogue associated with low peripheral fat in HIV
AIDS Date published: -
The influence of HLA supertype on thymidine analogue-associated with low peripheral fat in HIV
AIDS Date published: -
Predictors of Limb Fat Gain in HIV Positive Patients Following a Change to Tenofovir-Emtricitabine or Abacavir-Lamivudine
PLOS One Date published: -
Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial
AIDS Date published: -
Reply to Landmann and Soonawala
Clinical Infectious Diseases Date published: -
Simplification with fixed-dose tenofovir-emtricitabine or abacavir-lamivudine in treatment experienced, virologically suppressed adults with HIV infection: combined analysis of two randomized, non-inferiority trials BICOMBO and STEAL.
Journal of AIDS & Clinical Research Date published: -
Simplification with Fixed-Dose Tenofovir-Emtricitabine or Abacavir-Lamivudine in Treatment Experienced, Virologically Suppressed Adults with Hiv Infection: Combined Analysis of Two Randomised, Non-Inferiority Trials Bicombo and Steal
Journal of AIDS & Clinical Research Date published: -
Simplification of Antiretroviral Therapy with Tenofovir-Emtricitabine or Abacavir-Lamivudine: A Randomized, 96-Week Trial
Clinical Infectious Diseases Date published: -
Metabolic disorders and cardiovascular consequences of HIV infection and antiretroviral therapy
Expert Review of Clinical Pharmacology Date published: -
Adiponectin isoform distribution in women-relationship to female sex steroids and insulin sensitivity
Metabolism Date published: